Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Index levels are a useful barometer for market strength. This intro explains what index levels represent and how you can read them to inform your analysis.
27,688 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Headline drama can ripple through your finances. Learn practical steps to stay focused, protect your investments, and...
A new analysis argues that the traditional urge to start saving in your 20s may overstate the compounding payoff. Hig...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
XRP-linked ETFs are drawing persistent institutional inflows even as XRP trades in a tight $1.40-$1.47 range. A fresh...
A new flagship SUV from NIO sparked a notable jump in its stock as the ES9 price released below expectations. This ar...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
Space-focused investors have watched Redwire stock keep dropping as headlines swirl about contracts, funding, and exe...
Anthropic’s confidential $965 filing signals big ambitions in AI equity. This guide breaks down what it means, how pr...
A playful treadmill joke offers more than laughs. It reveals how strong money habits—like budgeting together, setting...
Hyperliquid's HYPE hovers around $39 after a daily dip, but a persistent rising channel and fresh institutional acces...